NCT02060318View on ClinicalTrials.gov

Regulatory T-cells and Crohn's Disease

CompletedOBSERVATIONAL
Enrollment

47

Participants

Timeline

Start Date

February 11, 2014

Primary Completion Date

March 7, 2016

Study Completion Date

March 7, 2016

Conditions
Crohn Disease
Interventions
DRUG

Infliximab

The patients are included in the study when the decision to treat with Infliximab is already made. This study is observational, and all treatment and clinical follow-up are according to national guidelines.

Trial Locations (1)

2650

Hvidovre Hospital, Hvidovre

All Listed Sponsors
lead

Hvidovre University Hospital

OTHER

NCT02060318 - Regulatory T-cells and Crohn's Disease | Biotech Hunter | Biotech Hunter